Stocks and InvestingStocks and Investing
Wed, May 4, 2022
Tue, May 3, 2022
Mon, May 2, 2022

Patrick Trucchio Maintained (ALNY) at Strong Buy with Increased Target to $430 on, May 2nd, 2022


Published on 2024-10-27 20:46:48 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $400 to $430 on, May 2nd, 2022.

Patrick has made no other calls on ALNY in the last 4 months.



There are 6 other peers that have a rating on ALNY. Out of the 6 peers that are also analyzing ALNY, 3 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $166 on, Friday, April 29th, 2022
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $96 on, Friday, April 29th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $170 on, Friday, April 29th, 2022


These are the ratings of the 3 analyists that currently disagree with Patrick


  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $211 on, Friday, April 29th, 2022
  • Etzer Darout of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $170 on, Thursday, February 3rd, 2022
  • Edward Tenthoff of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $208 on, Monday, January 3rd, 2022